The PeriGen Journey
During last week’s interview with Sramana Mitra, the founder of One Million by One Million, Emily Hamilton outlined the long, often winding journey taken from her seed research into labor progress at McGill University to the forming of PeriGen to today’s fast growth as more and more hospitals realize the patient safety benefits of applying advanced technology to labor & delivery patient care.
She detailed how McGill’s mission of enabling world-class expertise and her love of “tinkering” led to government funding for the collaboration of a group of mathematicians, engineers, and clinicians that developed a totally new method — a mathematical model — for measuring labor progress, one designed to assess whether progress is normal or significantly abnormal to require intervention.
Emily describes how the new product was tested in her own backyard in Canada where almost all Montreal hospitals tested and then rolled out the prototype. The hard part came with the attempt to extend reach into the Unites States.
“”It certainly was harder when I stepped outside of my backyard. With novel ideas, there’s a fair bit of skepticism as well. Obstetrics has a lot of medico-legal pressures so there’s a lot of fear of doing anything that’s new,” explains Emily.
Joining Emily Hamilton during the One Million by One Million interview, Matthew Sappern (PeriGen’s CEO) explained the next leg of the journey.
“PeriGen is actually the combination of a company called E&C Medical, originally based in Tel Aviv, and LMS, Emily’s company in Canada. E&C was trying to do pretty much what Emily’s team was rolling out. The companies were brought together under the name PeriGen to offer their compelling technologies within the US market,” says Matthew.
The combination has proved to be a powerful one. Under Matt’s leadership, PeriGen has gained avid evangelists for their technology among the obstetric and investing communities. The result has been significant growth and a remarkable level of traction, especially in the last 18 months.